Oprichting Intravacc B.V.

This procedure concerns the establishment of Intravacc B.V., a public limited company focused on vaccine development and production. It aims to strengthen the Netherlands' capacity in vaccine innovation and manufacturing. The establishment affects the public health sector and the biotechnology industry. It is intended to improve preparedness for future pandemics and enhance national vaccine security.